Tilray Inc. ($TLRY) Stock Forecast: Up 31.7% Today

What is Tilray Inc.?

Tilray Brands, Inc. (TLRY) is a prominent player in the cannabis industry, known for its innovative products and strategic growth initiatives. Recently, the stock displayed significant bullish momentum.

Why is Tilray Inc. going up?

TLRY stock is up 31.7% on Dec 12, 2025 14:45

• The introduction of Redecan's Amped Live Resin Liquid Diamond 1g 510 cartridges in Canada has sparked enthusiasm and market interest, contributing to Tilray's upward movement.
• Positive developments related to the legalization of home marijuana cultivation in Florida and potential changes in federal cannabis regulations have bolstered investor confidence in Tilray's future outlook.
• Despite facing challenges such as increased expenses and a stock price decline, Tilray's expansion strategies and focus on evolving into a diversified consumer packaged goods (CPG) company have resonated well with traders and investors, driving the bullish market performance observed today.
• The company's adept handling of regulatory shifts and its ability to seize opportunities within the cannabis sector are expected to be key factors influencing its stock performance in the immediate future.

TLRY Price Chart

TLRY Technical Analysis

TLRY News

Tilray Brands, Inc. Launches Redecan's First Live Resin Liquid Diamond 510 Cartridges in Canada

Tilray Brands, Inc. has introduced Redecan's Amped Live Resin Liquid Diamond 1g 510 cartridges in Canada, featuring true-to-strain flavors and advanced vaping technology. These cartridges combine Legit Live Resin with Liquid Diamonds for a full-spectrum experience and are designed to prevent clogs, with initial availability in Ontario and Alberta before national distribution in early 2026. The launch aims to capitalize on the growing Canadian live resin vape market.

https://www.quiverquant.com/news/Tilray+Brands%2C+Inc.+Launches+Redecan%27s+First+Live+Resin+Liquid+Diamond+510+Cartridges+in+Canada

Tilray (Nasdaq: TLRY) rolls out 1g Redecan Amped live resin vapes as 6.3% growth

Tilray Brands announced the launch of Redecan's Amped Live Resin Liquid Diamond 1g 510 cartridges, which are the brand’s first live resin–liquid diamond vape line, debuting Space Age CK and Blueberry DNTS on December 11, 2025. These vapes combine 80% Legit Live Resin with 20% Liquid Diamonds and are designed to preserve full-spectrum cannabinoids and strain-specific terpenes. The product is currently available in Ontario and Alberta, with national distribution expected by early 2026.

https://www.stocktitan.net/news/TLRY/redecan-cannabis-brand-elevates-the-diamond-vape-category-with-the-qie2xzpjllzz.html

Tilray Brands (TLRY) Goes 12.36% High as Senator Files New Cannabis Bill

Tilray Brands (NASDAQ:TLRY) stock surged by 12.36% after a new Florida Senate bill was filed to legalize home cultivation of marijuana. This legislative move, combined with President Donald Trump's support for reclassifying cannabis to Schedule II, boosted investor optimism. Jefferies also provided encouraging coverage for Tilray, anticipating benefits from potential federal cannabis restriction changes.

https://www.insidermonkey.com/blog/tilray-brands-tlry-goes-12-36-high-as-senator-files-new-cannabis-bill-1657697/?amp=1

Tilray Brands Inc: Is It the Moment for a Breakthrough?​

Tilray Brands Inc. (NASDAQ: TLRY) has seen its stock rise by 10.55%, driven by strategic expansions into new cannabis vape markets, unique branding collaborations, and a strong push towards becoming a diversified CPG company. Despite challenges with expenses outweighing revenue in its latest earnings report, the company shows financial stability with a solid quick ratio and current ratio, suggesting potential for significant growth if expense management and strategic market expansions are effectively executed. The article highlights both opportunities and financial considerations for traders and investors.

https://stockstotrade.com/news/tilray-brands-inc-tlry-news-2025_12_09/

Tilray stock flirts with death cross amid Trump’s silence on cannabis reform

Tilray Brands (TLRY) stock has plummeted recently, moving from $23.15 to $7.20, and is nearing a "death cross" pattern, indicating a bearish trend. The decline is attributed to a lack of cannabis reclassification progress from Donald Trump and headwinds in Tilray's beverage business, despite some positive results in cannabis revenue and debt reduction. The stock's future performance hinges on potential policy changes regarding cannabis reclassification.

https://www.tradingview.com/news/invezz:e6ea75b00094b:0-tilray-stock-flirts-with-death-cross-amid-trump-s-silence-on-cannabis-reform/

Trending Today

ZCash ($ZEC) Crypto Forecast: Down 5.3% Today

Tilray Inc. Price History

28.10.2025 - TLRY Stock was down 5.9%

• Tilray's stock took a hit today following the announcement of a 1-for-10 reverse stock split, which often signals a company's struggle to maintain its stock price.
• Despite posting strong Q1 cannabis growth and market share increases, the news of the reverse stock split overshadowed the positive performance, leading to a bearish trend.
• The market's reaction to the reverse stock split indicates investor concerns about Tilray's future prospects and financial health, contributing to the downward pressure on the stock price.
• Overall, the combination of the reverse stock split news and the market's response to it likely fueled the bearish movement in Tilray's stock today.

19.10.2025 - TLRY Stock was down 5.8%

• Despite posting a sharp profitability turnaround in Q1 and showcasing a strong global growth strategy, TLRY experienced a strong bearish movement.
• The market may have reacted negatively due to profit-taking after a significant run-up in the stock price following the positive Q1 results.
• Investors might be concerned about the sustainability of TLRY's profitability and growth strategy, leading to a sell-off in the stock.
• It's possible that the market was expecting even more impressive results or guidance, causing disappointment and triggering the bearish movement.

09.11.2025 - TLRY Stock was up 7.0%

• The launch of Tilray's Ultimate 2025 Holiday Drink Gift Guide featuring festive beverages may have sparked investor interest, hinting at potential expansion in the company's product range and consumer appeal.
• Following recent declines linked to internal changes, the stock saw a successful recovery, hitting a new 1-year peak, potentially influenced by heightened investor trust in Tilray's strategies and market position.
• Today's positive market outlook for Tilray could also be attributed to the overall industry optimism in the cannabis sector, with investors eyeing growth prospects in a sector shaped by changing consumer tastes and regulations.

10.09.2025 - TLRY Stock was down 15.8%

• The stock's sharp reversal today is possibly due to profit-taking by investors following the recent surge in its price.
• Despite reporting strong earnings and reducing its debt, a shift in market sentiment could have contributed to the bearish movement.
• While the overall market trend was positive on Thursday, with Tilray's stock climbing after good financial results, today's downward movement may indicate a correction or a reaction to the previous day's gains.
• Investors may be reconsidering their positions in Tilray amid market uncertainties, leading to the stock's decline despite a positive earnings surprise in the last quarter.

24.10.2025 - TLRY Stock was up 6.7%

• The introduction of Good Supply vape products in Québec by Tilray Brands could have sparked investor optimism and interest in the company's expansion into new markets, leading to increased buying activity and driving the stock price higher.
• The positive Q1 results and profitability momentum showcased by Tilray Brands indicate strong financial performance, which likely instilled confidence in investors and contributed to the bullish movement of the stock.
• The publication of a new investor presentation highlighting Tilray's leadership in various industries and its global growth strategy may have attracted new investors and bolstered existing shareholders' belief in the company's future prospects, potentially fueling the upward momentum in the stock price.

03.11.2025 - TLRY Stock was down 10.1%

• Tilray's stock has experienced a 24% drop over the past five sessions due to corporate restructuring and a reverse stock split.
• Negative company developments, including the reverse stock split and market pressures, have influenced the downward movement in TLRY's stock.
• Despite positive Q1 cannabis growth and a strengthened domestic position, the adverse effects of corporate changes have outweighed the positive news, leading to ongoing downward pressure on the stock.
• Investor response to Tilray's uncertainties and obstacles has caused the stock to decline further in line with broader market conditions.

16.09.2025 - TLRY Stock was down 11.4%

• A study linking medical cannabis to lower opioid use was likely a positive factor for investors initially.
• However, the company's expansion plans in Panama might not have met market expectations, causing uncertainty among investors.
• The stock's sharp reversal from hitting a new 52-week high could indicate profit-taking by traders, contributing to the bearish movement despite the positive news earlier in the week.

14.09.2025 - TLRY Stock was down 5.2%

• The bearish movement in Tilray's stock today could be attributed to profit-taking by investors after a recent surge in the stock price following the better-than-expected first-quarter earnings report.
• The expansion plans in Panama announced by Tilray Medical might not have had an immediate positive impact on the stock price, leading to a sell-off instead.
• The overall market sentiment towards cannabis stocks or sector rotation could have influenced the bearish movement in Tilray's stock, despite the upbeat results reported earlier in the week.
• Investors might be reacting to broader market trends or specific industry news, causing a shift in focus away from Tilray's positive developments towards other opportunities.

18.10.2025 - TLRY Stock was down 5.5%

• The bearish movement in TLRY stock today could be attributed to profit-taking by investors after a recent bullish run.
• Despite positive news about Tilray's global growth strategy and advocacy for responsible regulations, market sentiment may have been influenced by broader economic factors or sector rotation.
• Investors might be cautious due to the overall market volatility or specific concerns about the cannabis industry's regulatory environment.
• It's possible that some traders are reacting to technical indicators or short-term market fluctuations rather than the long-term potential of Tilray Brands.

12.10.2025 - TLRY Stock was down 5.5%

• Despite Tilray's optimistic outlook with a 94.5% surge in stock price and expanding global reach, the market movement today suggests a different sentiment.
• The bearish movement could be attributed to profit-taking by investors after the recent surge in stock price, leading to a temporary pullback.
• Additionally, the call for responsible hemp regulations by Tilray amidst regulatory uncertainties might have raised concerns among investors, impacting the stock price negatively.
• It's essential for investors to closely monitor how Tilray navigates through these challenges and regulatory changes to make informed decisions on whether to buy, sell, or hold the stock.

12.11.2025 - TLRY Stock was up 31.7%

• The introduction of Redecan's Amped Live Resin Liquid Diamond 1g 510 cartridges in Canada has sparked enthusiasm and market interest, contributing to Tilray's upward movement.
• Positive developments related to the legalization of home marijuana cultivation in Florida and potential changes in federal cannabis regulations have bolstered investor confidence in Tilray's future outlook.
• Despite facing challenges such as increased expenses and a stock price decline, Tilray's expansion strategies and focus on evolving into a diversified consumer packaged goods (CPG) company have resonated well with traders and investors, driving the bullish market performance observed today.
• The company's adept handling of regulatory shifts and its ability to seize opportunities within the cannabis sector are expected to be key factors influencing its stock performance in the immediate future.

10.11.2025 - TLRY Stock was up 12.0%

• Despite recent difficulties, Tilray (TLRY) witnessed a notable upward movement in the market today.
• This positive shift could be linked to the company's recent initiatives to expand into areas beyond its core cannabis business, such as broadening its beverage and hemp-derived THC product offerings.
• Investors seem hopeful about Tilray's potential for profitability despite ongoing losses, particularly with its focus on non-cannabis sectors to enhance profit margins.
• Today's optimistic market trend may also be driven by speculation regarding potential policy changes concerning the reclassification of cannabis, which could potentially benefit Tilray's future performance.